Eli Lilly and Co. received praise from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for its antibody …
Morgan Stanley upgraded Eli Lilly to Buy from Hold and raised the stock’s price target to $176 (17.7% upside potential) from $157, citing …
The pharmaceutical industry is considered to be more resilient in difficult economic times compared to other industries. However, this time around, the coronavirus-led …
Eli Lilly (LLY) has today announced patients have been dosed in the world’s first study of a potential antibody treatment designed to fight …
Drugmaker Eli Lilly & Co (LLY) said on Tuesday it has reduced the out-of-pocket cost for insulin to $35 per month to help …
Incyte Corporation (NASDAQ:INCY) and Eli Lilly and Company (NYSE:LLY) announced positive topline results of RA-BEAM, the fourth successful Phase 3 study of baricitinib, an …